Intron-size constraint as a mutational mechanism in Rothmund-Thomson syndrome

被引:55
作者
Wang, LL
Worley, K
Gannavarapu, A
Chintagumpala, MM
Levy, ML
Plon, SE
机构
[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA
[4] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA
关键词
D O I
10.1086/341234
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Rothmund-Thomson syndrome (RTS) is an autosomal recessive disorder caused by deleterious mutations in the RECQL4 gene on chromosome 8. The RECQL4 gene structure is unusual because it contains many small introns <100 bp. We describe a proband with RTS who has a novel 11-bp intronic deletion, and we show that this mutation results in a 66-bp intron too small for proper splicing. Constraint on intron size may represent a general mutational mechanism, since human-genome analysis reveals that similar to 15% of genes have introns <100 bp and are therefore susceptible to size constraint. Thus, monitoring of intron size may allow detection of mutations missed by exon-by-exon approaches.
引用
收藏
页码:165 / 167
页数:3
相关论文
共 15 条
[1]   EXON RECOGNITION IN VERTEBRATE SPLICING [J].
BERGET, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) :2411-2414
[2]   Rothmund-Thomson syndrome responsible gene, RECQL4:: Genomic structure and products [J].
Kitao, S ;
Lindor, NM ;
Shiratori, M ;
Furuichi, Y ;
Shimamoto, A .
GENOMICS, 1999, 61 (03) :268-276
[3]   Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome [J].
Kitao, S ;
Shimamoto, A ;
Goto, M ;
Miller, RW ;
Smithson, WA ;
Lindor, NM ;
Furuichi, Y .
NATURE GENETICS, 1999, 22 (01) :82-84
[4]   Initial sequencing and analysis of the human genome [J].
Lander, ES ;
Int Human Genome Sequencing Consortium ;
Linton, LM ;
Birren, B ;
Nusbaum, C ;
Zody, MC ;
Baldwin, J ;
Devon, K ;
Dewar, K ;
Doyle, M ;
FitzHugh, W ;
Funke, R ;
Gage, D ;
Harris, K ;
Heaford, A ;
Howland, J ;
Kann, L ;
Lehoczky, J ;
LeVine, R ;
McEwan, P ;
McKernan, K ;
Meldrim, J ;
Mesirov, JP ;
Miranda, C ;
Morris, W ;
Naylor, J ;
Raymond, C ;
Rosetti, M ;
Santos, R ;
Sheridan, A ;
Sougnez, C ;
Stange-Thomann, N ;
Stojanovic, N ;
Subramanian, A ;
Wyman, D ;
Rogers, J ;
Sulston, J ;
Ainscough, R ;
Beck, S ;
Bentley, D ;
Burton, J ;
Clee, C ;
Carter, N ;
Coulson, A ;
Deadman, R ;
Deloukas, P ;
Dunham, A ;
Dunham, I ;
Durbin, R ;
French, L .
NATURE, 2001, 409 (6822) :860-921
[5]   Characterization of the effects of mutations in the putative branchpoint sequence of intron 4 on the splicing within the human lecithin:cholesterol acyltransferase gene [J].
Li, M ;
Pritchard, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18079-18084
[6]  
Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO
[7]  
2-Z
[8]   Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA [J].
McCarthy, EMS ;
Phillips, JA .
HUMAN MOLECULAR GENETICS, 1998, 7 (09) :1491-1496
[9]   SPLICING MUTATIONS OF THE POLYCYSTIC-KIDNEY-DISEASE-1 (PKD1) GENE INDUCED BY INTRONIC DELETION [J].
PERAL, B ;
GAMBLE, V ;
MILLAN, JLS ;
STRONG, C ;
SLOANESTANLEY, J ;
MORENO, F ;
HARRIS, PC .
HUMAN MOLECULAR GENETICS, 1995, 4 (04) :569-574
[10]  
VANSANTEN VL, 1985, P NATL ACAD SCI USA, V82, P2885